ITK and cancer: In experimental models using multiple cell lines, we found that the ITK inhibitor Cmpd-5 significantly diminished the proliferation of cancer cells enhanced by ITK expression; however, the ITK inhibitor had no adverse impact on the proliferation of mock control cells.